Arctoris

Arctoris, founded in 2016, is positioned as a leading tech-enabled Partnership Research Organization (PRO) in the biotechnology sector, headquartered in Oxford, UK. The company is pioneering advancements in drug discovery by leveraging an innovative automation platform, Ulysses, alongside a team of top-tier laboratory scientists.

Their emphasis on quality data resonates in their core belief: "Better Data leads to Better Decisions." This commitment is reflected in their robust use of robotics and wet lab automation to generate expansive, reproducible datasets, which are instrumental for enhancing decision-making processes in drug discovery.

Arctoris stands out by integrating a comprehensive "ecosystem of excellence," with strategic partnerships across relevant disciplines, fostering agility and focus on client needs. The company recently secured a £2.00M early-stage VC investment. Operating within the nexus of AI, Automation, Biopharma, and Robotics, Arctoris represents a compelling investment opportunity in the evolving life sciences landscape.